Transcatheter Aortic Valve Implantation for Combined Aortic and Mitral Stenoses: Insights from the OCEAN-TAVI Registry

In patients undergoing TAVI for severe AS, those with moderate or severe MS experienced worse outcomes after TAVI compared with those without MS. Patients with combined AS and MS sustained symptom improvement at 1-year post-TAVI. MAC severity was a useful predictor of adverse events compared with MS haemodynamics such as TMG and MVA in patients with combined AS and MS.

Authors

Institutions

Publication Details

Journal
ESC Heart Failure
Published
2024-08-21
DOI
https://doi.org/10.1002/ehf2.15030
Citations
4
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
1.61

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Transcatheter Aortic Valve Implantation for Combined Aortic and Mitral Stenoses: Insights from the OCEAN-TAVI Registry

Hiroyuki Watanabe, Minoru Tabata, Masahiko Asami, Hiroshi Ueno et al.
4 citations
ESC Heart Failure
Cardiac Valve Diseases and Treatments
1.61
article

Transcatheter Aortic Valve Implantation for Combined Aortic and Mitral Stenoses: Insights from the OCEAN-TAVI Registry

Hiroyuki Watanabe, Minoru Tabata, Masahiko Asami, Hiroshi Ueno, Yohei Ohno, Fumiaki Yashima, Yusuke Watanabe, Masanori Yamamoto, Masahiko Noguchi, Nahoko Kato, Kentaro Hayashida, Toshiaki Otsuka, Kotaro Obunai, Joji Ito, Hidetaka Nishina, Futoshi Yamanaka, Masaki Izumo, Toru Naganuma, Masahiro Yamawaki, Norio Tada, Shinichi Shirai
article en
4 citations

Abstract

In patients undergoing TAVI for severe AS, those with moderate or severe MS experienced worse outcomes after TAVI compared with those without MS. Patients with combined AS and MS sustained symptom improvement at 1-year post-TAVI. MAC severity was a useful predictor of adverse events compared with MS haemodynamics such as TMG and MVA in patients with combined AS and MS.

ESC Heart FailureVol. 11(6)
Tokai University (JP), St. Marianna University School of Medicine (JP), Keio University (JP), Juntendo University (JP), New Tokyo Hospital (JP), Saiseikai Utsunomiya hospital (JP), Toyohashi Heart Center (JP), Mitsui Memorial Hospital (JP), Juntendo University Urayasu Hospital (JP), Tsukuba Medical Center Hospital (JP), Toyama University Hospital (JP), Nagoya Heart Center (JP), Shonan Kamakura General Hospital (JP), Saiseikai Yokohama Eastern Hospital (JP), Nippon Medical School Hospital (JP), Gifu Heart Center (JP), Kokura Memorial Hospital (JP), Nippon Medical School (JP), Teikyo University (JP)
Medtronic, Edwards Lifesciences, Boston Scientific Corporation, Abbott Medical Optics, Daiichi Sankyo Company, Daiichi Sankyo Europe
Life below water
Openalex Percentile: Top 15%
Cardiac Valve Diseases and Treatments
1.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.